ELIZABETH HARRIS: Open Payments
NPI 1629556832 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 33 payments from 14 companies in 2025. Trend: 2023 $788 · 2024 $1,340 · 2025 $853
Food & beverage: $802Education: $51
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $254 |
| Madrigal Pharmaceuticals | 4 | $133 |
| ABBVIE INC. | 5 | $120 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| QOL Medical, LLC | 1 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, ENTYVIO, RINVOQ, Sucraid, IQIRVO, OMVOH.
Industry payments across GA — which companies pay providers there.
